Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic

NCT04487171 | Unknown

• 1 other identifier: PI2020_843_0049
• Study Type: interventional
• Target: 248
• Locations: 1 country
• Sites: 1

Brief Summary

Postpartum depression (PPD) represent around 15% of birth in developed countries. The context of the COVID-19 epidemy represents a possible source of additional emotional distress. The objective of this study is to determine the screening prevalence and risk factors of postpartum depression, among women who deliver in fourth hospital in the North of France in the context of the COVID epidemy.

Conditions

Postpartum Depression; Covid19; Prevalence; Social Distance

Keywords

Postpartum Depression; Covid19; Prevalence; Social Distance

Outcome Measures

Primary Outcomes (1)

• Variation of prevalence of clinically-significant post-partum depressive symptoms

  Variation of prevalence of clinically-significant post-partum depressive symptoms

  up to 35 days after delivery

Interventions

Questionnaire OTHER

The mothers were administrated three questionnaires, (i) the Edinburgh Postnatal Depression Scale (EPDS), (ii) the State-Trait Anxiety Inventory (STAI-YA), and (iii) the Mother-to-Infant Bonding Scale (MIBS) in two stages, on days 2-3 after delivery and during a phone call between days 25-35.

Eligibility Criteria

• Age: 18 Years+
• Gender Eligibility Details: women who deliver
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Single baby delivery
• alive new born child without admission in neonatal intensive care unit
• French-speaking mother
• mother older than 18 years old

Sponsors & Collaborators

• Centre Hospitalier Universitaire, Amiens: lead
• Centre Hospitalier de Beauvais: collaborator
• Central Hospital Saint Quentin: collaborator
• Centre Hospitalier Compiègne: collaborator

Study Sites (1)

CHU Amiens

Amiens, 80480, France

RECRUITING

MeSH Terms

Conditions

Depression, Postpartum; COVID-19

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Puerperal Disorders; Pregnancy Complications; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Depressive Disorder; Mood Disorders; Mental Disorders; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Arthur FOULON, MD

  CHU Amiens

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Arthur FOULON, MD

CONTACT

(33)322087382; foulon.arthur@chu-amiens.fr

Xavier BENAROUS, MD

CONTACT

(33)322087630; benarous.xavier@chu-amiens.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 24, 2020
• First Posted: July 27, 2020
• Study Start: July 21, 2020
• Primary Completion: July 1, 2023
• Study Completion: August 1, 2023
• Last Updated: March 22, 2023

Record last verified: 2023-03

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)